Cargando…

Electrophysiological Studies in Patients with Pulmonary Hypertension: A Retrospective Investigation

Few studies have investigated patients with pulmonary hypertension and arrhythmias. Data on electrophysiological studies in these patients are rare. In a retrospective dual-centre design, we analysed data from patients with indications for electrophysiological study. Fifty-five patients with pulmona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandorski, Dirk, Schmitt, Jörn, Kurzlechner, Claudia, Erkapic, Damir, Hamm, Christian W., Seeger, Werner, Ghofrani, Ardeschir, Höltgen, Reinhard, Gall, Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058223/ https://www.ncbi.nlm.nih.gov/pubmed/24977152 http://dx.doi.org/10.1155/2014/617565

Ejemplares similares

Incidence and prognostic significance of malignant arrhythmias during (repetitive) Holter electrocardiograms in patients with pulmonary hypertension
por: Bandorski, Dirk, et al.
Publicado: (2023)

Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary Hypertension
por: Bandorski, Dirk, et al.
Publicado: (2016)

Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study
por: Gall, Henning, et al.
Publicado: (2016)

Heart Rate Variability is Related to Disease Severity in Children and Young Adults with Pulmonary Hypertension
por: Latus, Heiner, et al.
Publicado: (2015)

Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angioplasty
por: Ley, Lukas, et al.
Publicado: (2023)

Follow-Up (Measurement) of Corrected QT Interval in Adult Patients before and after Lung Transplantation
por: Bandorski, Dirk, et al.
Publicado: (2017)

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
por: Schermuly, Ralph Theo, et al.
Publicado: (2005)

Editorial: Innovative strategies for the management of life threatening ventricular tachyarrhythmias—from substrate analysis to differential therapy
por: Höltgen, Reinhard, et al.
Publicado: (2023)

Hepatorenal dysfunction in patients with chronic thromboembolic pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Estimated plasma volume status: association with congestion, cardiorenal syndrome and prognosis in precapillary pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Capsule endoscopy in patients with cardiac pacemakers, implantable cardioverter defibrillators and left heart assist devices
por: Bandorski, Dirk, et al.
Publicado: (2014)

Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
por: Gall, Henning, et al.
Publicado: (2021)

Poor sleep quality is associated with exercise limitation in precapillary pulmonary hypertension
por: Tiede, Henning, et al.
Publicado: (2015)

Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension
por: Grimminger, Jan, et al.
Publicado: (2017)

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Effects of riociguat in severe experimental pulmonary hypertension
por: Kojonazarov, Baktybek, et al.
Publicado: (2011)

The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Relevance of Cor Pulmonale in COPD With and Without Pulmonary Hypertension: A Retrospective Cohort Study
por: Yogeswaran, Athiththan, et al.
Publicado: (2022)

Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
por: Richter, Manuel J., et al.
Publicado: (2019)

New horizons in pulmonary arterial hypertension therapies
por: Galiè, Nazzareno, et al.
Publicado: (2013)

Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension
por: Veeroju, Swathi, et al.
Publicado: (2021)

The molecular targets of approved treatments for pulmonary arterial hypertension
por: Humbert, Marc, et al.
Publicado: (2016)

The role of combination therapy in managing pulmonary arterial hypertension
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2014)

Reply to Bogaard et al.: Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Kojonazarov, Baktybek, et al.
Publicado: (2019)

The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats
por: Lang, Michaela, et al.
Publicado: (2011)

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations
por: Pfarr, Nicole, et al.
Publicado: (2011)

Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice
por: Seimetz, Michael, et al.
Publicado: (2015)

Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2019)

Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension
por: Sklepkiewicz, Piotr, et al.
Publicado: (2011)

Physical Activity and Mental Health of Patients with Pulmonary Hypertension during the COVID-19 Pandemic
por: Dobler, Carolin Leoni, et al.
Publicado: (2020)

Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension
por: Rai, Nabham, et al.
Publicado: (2022)

Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives
por: Husain‐Syed, Faeq, et al.
Publicado: (2020)

Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension
por: Thamm, Melanie, et al.
Publicado: (2011)

Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres
por: Wissmüller, Max, et al.
Publicado: (2022)

IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension
por: Biswas, Siladitta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a4l902dgqpn31a4ktsor3sb35h